FDA Scrutiny of Promotion and Advertising Practices is a seminar that covers topics such as:
- How FDA faces constitutional constraints on enforcement decisions
- Intersecting federal requirements by the Department of Justice, the Federal Trade Commission, the Securities and Exchange Commission and the Consumer Product Safety Commission
- Ways that a firm violates FDA requirements
- How the FDA interprets advertising and promotion in principle and in fact
- How sales and marketing departments play a central role, for better or worse
- Advertising and promotional material based on interactive group hypotheticals
- How the federal government holds executive management responsible for missteps in promotion and advertising practices
FDA Scrutiny of Promotion and Advertising Practices brings together:
- Regulatory Managers
- Sales and Marketing executives and managers
- 3rtd party consultants
- In-house Legal Counsel and Contract Specialists
- Investors
- Venture Capitalists
- Owners of New or Developing Firms
- Business Acquisition Executives
- International Trade Managers
- Own label distributors
- Product specification developers